INDV Indivior Pharmaceuticals Inc
USHealthcareAs of 2026-07-10 11:26
Why INDV matters now
Indivior Pharmaceuticals Inc (INDV) is a US stock in Healthcare. The latest InvestLog snapshot shows $40.54 with -1.83% on the session and $5.06B in market capitalization; recent performance reads 1-month +3.54% and YTD +6.74%.
The latest financial table shown here is Q1 2026, with revenue of $317.0M, net income of $89.0M, and EPS of $0.69. Investors can compare that operating picture with valuation signals such as P/E 18.15 and FCF yield -3.9%.
The latest indexable market news headline is "Indivior Pharmaceuticals Inc. (INDV) is on the Move, Here's Why the Trend Could be Sustainable" from Zacks Investment Research.
Additional event context on this page matters because analyst consensus is Buy with a median target of $48.00; recent insider activity includes Heidbreder Christian filing S-Sale. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
18.15
PEG
0.03
P/B
-33.34
P/S
3.70
EV/EBITDA
14.52
DCF Value
$2.73
FCF Yield
-3.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
83.1%
Operating Margin
33.3%
Net Margin
19.4%
ROE
-142.0%
ROA
21.0%
ROIC
85.7%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $317.0M | $89.0M | $0.69 |
| Q4 2025 | $358.0M | $102.0M | $0.82 |
| FY 2025 | $1.24B | $210.0M | $1.64 |
| Q3 2025 | $314.0M | $42.0M | $0.33 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$48.00
Target (Median)
$48.00
Target Range
$46.00 - $50.00
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
US
Exchange
—
Beta
1.17
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.